Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-0.662 %
$ 60.4 M
Market Cap
-1.22
P/E
IKNA - STOCK-BASED COMPENSATION
Stock-based Compensation IKNA - Ikena Oncology, Inc.
7.63 M
LAST VALUE
21.42%
2 YEAR CAGR
89.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR